ELISPOT Assay for Interferon γ Detection

The question describes an experiment using the ELISPOT assay to detect interferon γ (IFNγ) production by peripheral blood mononuclear cells (PBMCs) from a tuberculosis (TB) patient. The goal is to identify which of the four lab technicians performed the assay correctly to get a reliable result for IFNγ specific to TB antigens.

The ELISPOT assay is a powerful tool used to measure the frequency of cytokine-producing cells within a population. In the context of TB, it is often used to detect T cells that specifically recognize TB antigens and respond by producing IFNγ or other cytokines.

For a standard IFNγ ELISPOT assay using PBMCs to detect a response to a specific antigen, the following key steps are generally involved:

1. Coating the wells of a special plate with an antibody specific to the cytokine (IFNγ) you want to detect.
2. Adding PBMCs to the wells. These cells contain the T cells that might respond to the antigen.
3. Adding the specific antigen (TB-specific antigen in this case) to stimulate the cells. If the patient has been exposed to TB, their T cells specific for that antigen will be activated.
4. Incubating the plate to allow activated cells to produce and secrete the cytokine. The secreted cytokine is captured by the antibody coated on the plate surface.
5. Washing away the cells.
6. Adding a detection antibody (often biotinylated) which binds to the captured cytokine.
7. Adding an enzyme-conjugated molecule (like streptavidin-enzyme conjugate) that binds to the detection antibody.
8. Adding a substrate that reacts with the enzyme to produce a visible spot. Each spot represents a single cell that produced and secreted the cytokine.

Analysis of Lab Technician Methods for ELISPOT

Let's evaluate the method used by each lab technician:

• Lab technician 1: Coated wells with formaldehyde-treated cells and stimulated with TB-specific antigen. Formaldehyde treatment fixes cells, killing them and preserving their structure. However, living, metabolically active cells are required to produce and secrete cytokines like IFNγ upon stimulation. Fixing the cells before stimulation or incubation will prevent cytokine production and secretion, leading to a negative or incorrect result.
• Lab technician 2: Coated wells with cells but did not stimulate with TB-specific antigen. The ELISPOT assay for detecting antigen-specific T cell responses requires the presence of the specific antigen to activate those T cells. Without stimulation by the TB-specific antigen, the antigen-specific T cells will not be activated to produce IFNγ, resulting in no spots or only background spots.
• Lab technician 3: Depleted T cells completely, coated wells with monocyte-enriched PBMCs, and stimulated with TB-specific antigen. While monocytes can produce some cytokines, the primary source of antigen-specific IFNγ production in response to TB antigens in PBMCs is from T cells (specifically CD4+ and CD8+ T cells). Depleting T cells completely removes the main cell population responsible for the expected response, leading to an incorrect result.
• Lab technician 4: Coated wells with 250,000 cells (presumably PBMCs) and stimulated the cells with TB-specific antigens. This method follows the standard approach for stimulating PBMCs with a specific antigen to induce IFNγ production by reactive T cells. Assuming all other steps of the ELISPOT assay were followed correctly, this method should yield a correct result by detecting the frequency of TB-specific IFNγ-producing cells in the patient's PBMCs.

Based on the fundamental principles of the ELISPOT assay for detecting antigen-specific cytokine production by T cells, the method used by Lab technician 4 is the correct approach among the options provided.